About PharmaCore
PharmaCore is a Healthcare company based in High Point (United States) founded in 2000, and was acquired by Cambrex in September 2016. Contract services for API discovery, development, and manufacturing are provided. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.
Company details
PharmaCore offers custom synthesis, analytical, GMP manufacturing and quality assurance services for biopharma companies. Its services are catered to meet the needs of its customers from lead discovery to lead optimization, chemical synthesis and scale-up of pharmaceutical intermediates as well as chemical process RD. They provide non GMP and GMP API manufacture from grams to 100s of kilograms for both clinical and commercial applications. They have a Quality Assurance department that assures compliance with current FDA and international regulations. They are also capable of offering a diverse range of analytical testing capabilities and experienced methods like development and validation services, ICH stability studies etc., They offer contract research and manufacturing services for controlled substances in Schedules II to V.
- Headquarters High Point, United States
- Stage Acquired
- SectorsHealthcare
- Website pharmacore.com
- Social LinkedIn
- Acquired by Cambrex (Sep 2016)
Investors in PharmaCore
PharmaCore has secured backing from 1 investor. Prominent investors backing the company include Cambrex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CDMO of complex small molecule APIs, including highly potent APIs | 1981 | cambrex.com | East Rutherford, United States |
Investor details for PharmaCore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PharmaCore
1 people are tracked at PharmaCore (1 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Loewald | CEO | Leadership |
Complete people profiles for PharmaCore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PharmaCore
2 dated milestones of PharmaCore across 16 years, from founding to its latest funding, stage changes and deals.
- Founded PharmaCore is founded.
- Exit Acquired by Cambrex.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as PharmaCore (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PharmaCore
PharmaCore was founded in 2000.
PharmaCore is headquartered in High Point, United States. It is registered at High Point, North Carolina, United States.
PharmaCore offers custom synthesis, analytical, GMP manufacturing and quality assurance services for biopharma companies. Its services are catered to meet the needs of its customers from lead discovery to lead optimization, chemical synthesis and scale-up of pharmaceutical intermediates as well as chemical process RD. They provide non GMP and GMP API manufacture from grams to 100s of kilograms for both clinical and commercial applications. They have a Quality Assurance department that assures compliance with current FDA and international regulations. They are also capable of offering a diverse range of analytical testing capabilities and experienced methods like development and validation services, ICH stability studies etc., They offer contract research and manufacturing services for controlled substances in Schedules II to V.
PharmaCore has 1 investor. Key investors include Cambrex.
Yes. PharmaCore was acquired by Cambrex in September 2016.